Approval granted by Bulgarian Drug Agency
GCT is delighted to announce that we received the approval to conduct a Phase III epilepsy trial in Bulgaria for our long-term partner, a US pharmaceutical company.
The task was completed in just 50 working days.
Updated: April 14, 2016
Permanent link: https://2022.gctrials.com/news/approval-granted-by-bulgarian-drug-agency/